CervoMed Inc. Preferred Stock, Par or Stated Value Per Share
CervoMed Inc. (CRVO) had Preferred Stock, Par or Stated Value Per Share of $0.00 per share as of 2024-03-31, per its 10-Q filed 2024-05-14.
Discontinued › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Preferred Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:PreferredStockParOrStatedValuePerShare · last filed 2024-05-14
- 2024-03-31: Preferred Stock, Par or Stated Value Per Share $0.00.
- 2023-12-31: Preferred Stock, Par or Stated Value Per Share $0.00.
- 2015-12-31: Preferred Stock, Par or Stated Value Per Share $0.00.
- 2014-12-31: Preferred Stock, Par or Stated Value Per Share $0.00.
| Period end | Preferred Stock, Par or Stated Value Per Share |
|---|---|
| 2024-03-31 | $0.00 10-Q · filed 2024-05-14 |
| 2023-12-31 | $0.00 10-Q · filed 2024-05-14 |
| 2015-12-31 | $0.00 10-K · filed 2016-03-25 |
| 2014-12-31 | $0.00 10-K · filed 2015-04-03 |
| 2012-06-30 | $0.00 10-Q/A · filed 2012-09-07 |
| 2011-12-31 | $0.00 10-Q/A · filed 2012-09-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |